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Background: Sub-Saharan Africa (SSA) has the highest prevalence of HIV globally, and 
this is due to persistent new HIV infections and decline in HIV/AIDS-related mortality 
from improved access to antiretroviral (ART) therapy. There is a limited body of work on 
perspectives of health-care providers (HCPs) concerning disclosing outcomes of HIV 
investigations to children and adolescents in SSA. Most studies are country-specific, 
indicating a need for a regional scope.
Objective: To review the current literature on the perspectives of HCPs and caregivers of 
children and adolescents on age group-specific and culture-sensitive HIV disclosure practice.
Methods: Electronic database search in PubMed, Google scholar, and the University of 
South Florida Library Discovery Tool (January 2006 up to February 2016). Further inter-
net search was conducted using the journal author name estimator search engine and 
extracting bibliographies of relevant articles. Search terms included “disclosure*,” “HIV 
guidelines,” “sub-Saharan Africa,” “clinical staff,” “ART,” “antiretroviral adherence,” “people 
living with HIV,” “pediatric HIV,” “HIV,” “AIDS,” “health care provider,” (HCP), “caregiver,” 
“adolescent,” “primary care physicians,” “nurses,” and “patients.” Only studies related to 
HIV/AIDS disclosure, HCPs, and caregivers that clearly described perspectives and inter-
actions during disclosure of HIV/AIDS sero-status to affected children and adolescents 
were included. Independent extraction of articles was conducted by reviewers using pre-
defined criteria. Nineteen articles met inclusion criteria. Most studies were convenience 
samples consisting of combinations of children, adolescents, HCPs, and caregivers. Key 
findings were categorized into disclosure types, prevalence, facilitators, timing, process, 
persons best to disclose, disclosure setting, barriers, and outcomes of disclosure.
Conclusion: Partial disclosure is appropriate for children in SSA up to early adolescence. 
Caregivers should be directly involved in disclosing to children but they require adequate 
disclosure support from HCPs. Full disclosure is suitable for adolescents. Adolescents 
prefer disclosure by HCPs and they favor peer-group support from committed peers 
and trained facilitators, to reduce stigma. HCPs need continuous training and adequate 
resources to disclose in a patient-centered manner.
Keywords: Hiv disclosure, children and adolescents, health-care providers, caregivers, sub-Saharan Africa, 
ART adherence
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iNTRODUCTiON
The HIV pandemic is one of the most severe public health 
challenges facing the world to date. This pandemic has grave 
economic implications, especially in high prevalent regions like 
sub-Saharan Africa (SSA) (1, 2). The global HIV burden is esti-
mated at 36.9 million cases; by the end of 2014, approximately 2 
million new cases and 34 million deaths were attributed to AIDS-
related causes (3–6). Recent data indicate that the top 10 ranking 
of HIV/AIDS cases by country is populated by countries in SSA 
(5, 6). In 2015, SSA contributed to 70% of new cases globally (5, 
6). Factors contributing to the prevalence of HIV in SSA include 
improved access to antiretroviral (ART) medications and the 
resultant decline in mortality, while new infections from HIV/
AIDS persist (1, 7).
Majority of new HIV infection cases occur in low- and 
middle-income countries that lack properly defined guidelines 
or resources to equip HCPs (3, 8, 9). HIV disclosure may be one 
of the critical links between new infections and the sustained 
high prevalence in SSA (10, 11). Inadequate health-care provider 
(HCP) training in HIV disclosure and testing services appear 
to contribute to new cases. Unfortunately, limited body of work 
exists on the prevalence and practice of disclosure by HCPs in SSA 
(7). Over the last 15 years, there has been a 35% decrease in global 
HIV infections and a 58% decrease among children, yet more 
than 54% of children currently infected may be unaware they 
have the disease (6, 12). A study on resource-limited countries 
that had available disclosure rates (Ghana, Kenya, and Ethiopia) 
reported rates that varied from 11 to 38% (11, 13, 14). This vari-
ability is consistent with studies in resource-rich countries where 
disclosure rates to children range widely from 10 to 77% (15–17). 
Furthermore, HIV disclosure practices in SSA remain complex 
due to the immense influence of culture, politics, and limited 
HIV surveillance (5, 10, 18). Disclosure rates in high prevalence 
regions need to be evaluated and improved drastically in a timely 
manner as HIV disclosure may be a key factor in reducing the risk 
of acquiring new infections, adherence to ARTs, and practice of 
safe sexual behaviors (7, 10, 19, 20).
Taken together, the incidence of HIV infection in SSA may be 
reduced by understanding the perspectives and roles of HCPs and 
caregivers in disclosing laboratory HIV test outcomes to children 
and adolescents in this region. In addition, studies in this region 
are country-specific; therefore, evaluating the perspectives of 
HCPs and caregivers across countries may provide more insight 
to achieve more reduction in new HIV infections. To determine 
the perspectives of HCPs and caregivers on age group-specific and 
culturally sensitive HIV disclosure practices in SSA, a systematic 
review of the perspectives and current patterns of HIV disclosure 
among HCPs and caregivers of children and adolescents was 
conducted.
MeTHODS
We searched for quantitative, qualitative (focus groups, 
interviews, and surveys), and mixed methods studies on HIV 
disclosure involving HCPs and caregivers in SSA from January 
1, 2006 to February 28, 2016. English language restriction was 
imposed. Study participants included combinations of children 
and adolescents, HCPs and caregivers, or only caregivers or 
HCPs. Disclosure was categorized as full disclosure, partial dis-
closure, and non-disclosure (12, 21). Full disclosure is complete 
disclosure of HIV status with the term “HIV” appropriately used 
(11, 12, 21). In this case, the potential causes, transmission, and 
impact of the disease were discussed and treatment was clarified. 
Partial disclosure was performed similarly to full disclosure but 
the terms “HIV” or “AIDS” were excluded despite describing 
the morbidity and mortality from the disease (12, 21, 22). Other 
aspects present in full disclosure may also be excluded, for exam-
ple, counseling (20, 21). Non-disclosure signifies no disclosure. 
In this case, individuals are not provided any information about 
their positive HIV status (12, 21).
The term “health-care providers” refers to health-care profes-
sionals, such as clinical staff, primary care physicians, nurses, 
midwives, and any health personnel, providing patient care in a 
clinical setting. A caregiver includes parents, family members, or 
individuals caring for a child or adolescent living with HIV/AIDS 
in a non-clinical/professional capacity. Articles were selected on 
application of the following inclusion criteria: social science work 
that examined HIV disclosure through qualitative or quantitative 
studies and mixed methods that clearly described perspectives 
and interactions among HCPs, caregivers, and infected children 
and adolescents.
Search Strategy and Search Procedure
A computer-assisted systematic review was conducted, and 
extraction of articles was independently performed by the three 
authors who have expertise in community and family health, global 
health, epidemiology, and HIV management. Disagreements 
between reviewers were resolved by consensus. Three major 
electronic databases were searched using dates January 1, 2006 
to February 28, 2016. These bibliographic databases included 
PubMed, Google Scholar, and the University of South Florida 
(USF) Library Discovery Tool. For USF Library Discovery Tool 
and PubMed, the term “HIV AIDS disclosure” was searched, then 
the Boolean operator and last set of terms “health-care provider” 
OR “caregiver” OR “patient” OR “adolescent” were added. Finally, 
the inclusion criteria were applied.
For Google Scholar, the term “HIV disclosure” was searched 
then “AIDS disclosure” and “sub-Saharan Africa” were added. 
Next, the Boolean operator and keyword “health-care providers” 
OR “caregiver” OR “patient” OR “pediatric” OR “health-care 
professionals” were added. Finally, the inclusion criteria were 
applied. An additional internet search was conducted in Journal 
Author Name Estimator database (JANE) using the proposed 
search terms and their variants. Additional articles were cross 
referenced for further review of all the articles, and some articles 
were excluded either because they did not meet the inclusion 
criteria of the review or they were duplicates. Figure 1 shows a 
flow diagram of the search process.
Variants of keywords for HCP, caregiver, HIV and AIDS, 
and disclosure were also used. The search strategy was limited 
to articles that were accessible through the USF library. Full-text 
articles of all selected studies were retrieved, and if an article 
was selected, the bibliographic references were examined for 
FigURe 1 | Flow chart of Hiv disclosure systematic review search 
process.
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additional relevant studies. Caregivers, HCP, and patients were 
combined with the use of the Boolean operator “OR.” The above 
searches, based on the two main interest HIV/AIDS disclosure 
and SSA, were combined using the Boolean operator “AND.”
Data extraction
A data extraction sheet was developed by two of the authors 
(Oluyemisi Aderomilehin and Angella Hanciles-Amu) and reviewed 
by the third author (Oluwatobi Ohiole Ozoya). A total of 19 articles 
met the inclusion criteria. First author, year and title of publication, 
country of study, population characteristics, study design, and 
theme topics were included in the sheet (Table 1). A summary of the 
results from included studies that were relevant to perspectives and 
practice of HIV disclosure to children and adolescents are detailed 
in Table 2.
ReSULTS
All studies in the final selection included various types of studies 
ranging from 13 qualitative study design, including interviews 
and focus groups (23, 24, 27, 28, 30–32, 34–36, 39, 40), to 4 quan-
titative study design (21, 26, 33, 37) and 2 mixed methods design 
(25, 38). The 19 articles included studies conducted in 10 SSA 
countries. The sample sizes were variable, ranging from 21 to 858 
(median 79). Most studies utilized small samples, with the largest 
four studies including 40 HCPs (34), 394 caregivers (26), and 858 
children and adolescents (38). Three studies included only HCPs 
(32, 34, 40), and five studies included only caregivers (29–31, 37, 
39). One study included both HCPs and community members 
with focus on HIV disclosure and discussions about grief (21). 
The three studies that included only HCPs-provided information 
on types of disclosure in practice and the most suitable person 
and setting to disclose (32, 34, 40). Some of the studies included 
caregivers living with HIV and others without HIV. Caregivers 
were involved in the care of HIV-positive children, adolescents, or 
family members (29–31, 37, 39). Estimation of disclosure preva-
lence was limited to two articles (37, 38). The studies explored 
perspectives on disclosure types, prevalence, facilitators, timing, 
process, persons best to disclose, disclosure setting, barriers, and 
outcomes of disclosure. This is described below.
Types and Prevalence of Hiv Disclosure
Disclosure was defined by mention of “HIV or AIDS” when 
explaining the illness to infected children and adolescents, 
implying full disclosure, otherwise, partial disclosure is the case 
(21, 24, 26, 33, 34, 38, 40). Non-disclosure was present in two 
studies where the children were neither aware of the illness nor 
the reason for taking medications (33, 39).
Only two studies reported on prevalence of HIV disclosure 
estimated at 30.9% among infected children and 68.1% among 
infected adolescents (37, 38). In these studies, the infected chil-
dren and adolescents were aware of their HIV infection, indicat-
ing full disclosure. Three other qualitative studies reported less 
than half of caregivers who had disclosed to their children (25, 
29, 39). Two studies reported non-disclosure by 50% of caregivers 
and simultaneously reported partial disclosure by 15–24.6% of 
caregivers (33, 39).
Facilitators and Timing of Disclosure Type
Major facilitators for caregivers in initiating disclosure was 
knowledge of availability of ART therapy (29), view of dis-
closure as the right of the child and adolescent (29, 41) when 
adhering to ART therapy was a potential or actual problem for 
the infected child or there was frequent visits to health facilities 
despite absence of overt illness (37, 39). Other facilitators to HIV 
disclosure include persistent inquiries by the HIV-positive child 
or adolescent (36, 37), presence of chronic illness in the child or 
a family member (31, 39), or discovery at routine antenatal clinic 
attendance by infected mothers (36). A common predictor of the 
timing of disclosure to children was the age of the child; the age 
for disclosure varied widely among the studies and ranged from 5 
to 15 years (21, 26, 29, 31, 33–37). Studies that reported a specific 
age of disclosure to children included 5 years (36), 7 years (31), 
above 10 years (33, 34, 37), 12 years (29), and 15 years (26, 35). 
Three studies distinguished age at full disclosure as above 10 years 
(34, 36), 14 years (21), and 15 years (26). Two studies specifically 
reported partial disclosure by caregivers at ages <10 years (21, 34, 
36) and 15 years (26, 35).
Process of Hiv Disclosure
Irrespective of whether it was a HCP or caregiver being 
interviewed, some of the studies indicated that the process of 
disclosure can be complex (23, 24, 26, 29, 37–40). One study 
reported caregivers who perceived disclosure as a single event 
(30). Only one study reported different phases of disclosure that 
included pre-disclosure, disclosure, and post-disclosure phases 
TABLe 1 | Study characteristics.
Study Title Location Population sample size Study design and methods 
of data collection
Key findings
1 Mburu et al. 
(23)
Adolescent HIV disclosure in 
Zambia: barriers, facilitators, and 
outcomes
Zambia 223
•	 164 adolescents
•	 21 parents/caregivers
•	 38 HCPs
Qualitative (interviews and 
focus group discussions)
•	 Barriers
•	 Outcomes of HIV disclosure
2 De Baets 
et al. (21)
HIV disclosure and discussions 
about grief with Shona children: a 
comparison between health-care 
workers and community members 
in Eastern Zimbabwe
Zimbabwe 195
•	 131 community 
members
•	 64 HCPs in primary/
rural health centers
Quantitative (anonymous 
survey)
•	 Age of disclosure
•	 Best person to disclose 
to child 
3 Demmer 
(24)
Experiences of families caring for an 
HIV-infected child in KwaZulu-Natal, 
South Africa:  
an exploratory study
South Africa 25
•	 13 caregivers (mothers/
females with a biological 
child sick from HIV/
AIDS)
•	 12 HCPs of children 
and families living with 
HIV/AIDS.
Qualitative (in-depth interview 
and semi-structured 
interview)
•	 Barriers to disclosure
4 Gyamfi 
et al. (25)
Benefits of disclosure of HIV 
status to infected children and 
adolescents: perceptions of 
caregivers and health-care 
providers
Ghana 118
•	 118 caregivers of HIV-
infected children and 
adolescents.
•	 10 key informants–
HCPs and volunteer 
workers
Mixed method (quantitative 
and qualitative)
•	 Best person to disclose
•	 Proportion
•	 Benefits of disclosing
5 Kajubi et al.  
(26)
Communication between 
HIV-infected children and their 
caregivers about HIV medicines: 
a cross-sectional study in Jinja 
district, Uganda
Uganda 394
•	 394 children and their 
caregivers
Quantitative (cross-sectional 
survey)
•	 Disclosure communication 
pattern
•	 Age (full/partial disclosure)
6 Kidia et al. 
(27)
HIV-status disclosure to 
perinatally-infected adolescents in 
Zimbabwe: a qualitative study of 
adolescent and health-care worker 
perspectives
Zimbabwe 46
•	 31 perinatally infected 
adolescents
•	 15 HCPs
Qualitative (in-depth 
interviews with adolescents; 
focus groups with HCPs)
•	 Best person to disclose
•	 Disclosure setting
•	 Support
7 Midtbo 
et al. (28)
How disclosure and antiretroviral 
therapy help HIV-infected 
adolescents in sub-Saharan Africa 
cope with stigma
Botswana 14
•	 12 adolescents
•	 2 HCPs
Qualitative (interviews and 
observation)
•	 Stigma
•	 Coping following disclosure
Tanzania 19
•	 16 adolescents
•	 3 HCPs
8 Moodley 
et al. (29)
Paediatric HIV disclosure in South 
Africa – caregivers’ perspectives on 
discussing  
HIV with infected children
South Africa 174
•	 caregivers and children 
living with HIV
Qualitative (semi-structured 
interviews)
•	 Disclosure proportion
•	 Age of child at disclosure
•	 Best person
•	 Facilitators
•	 Barriers
9 Kiwanuka 
et al. (30)
Caregiver perceptions and 
motivation for disclosing or 
concealing the diagnosis of HIV 
infection to children receiving HIV 
care in Mbarara, Uganda:  
a qualitative study
Uganda 40
•	 Primary caregivers of 
HIV-infected children 
receiving HIV care but 
ignorant of their HIV 
status
Qualitative (in-depth 
interviews)
•	 Disclosure-single event/
process?
•	 Benefits and barriers
10 Lorenz et al. 
(31)
Caregivers’ attitudes towards HIV 
testing and disclosure of HIV status 
to at-risk children in rural Uganda
Uganda 28
•	 Caregivers of HIV-
positive children
Qualitative (semi-structured 
interviews)
•	 Facilitators to testing child
•	 Age at disclosure
•	 Barriers
•	 Type of disclosure
•	 Support
(Continued)
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Study Title Location Population sample size Study design and methods 
of data collection
Key findings
11 Beima-Sofie 
et al. (32)
Using health provider insights to 
inform pediatric HIV disclosure: 
a qualitative study and practice 
framework from Kenya
Kenya 21
•	 HCPs
Qualitative (interviews) •	 HCPs disclosure practices
•	 Family-centered disclosure
•	 Best Person to disclose
•	 Outcomes of disclosure
12 Mumburi 
et al. (33)
Factors associated with HIV-status 
disclosure to HIV-infected children 
receiving care at Kilimanjaro 
Christian Medical Centre in Moshi, 
Tanzania
Tanzania 236
•	 211 parents or 
caregivers and their 
children
•	 25 HCPs
Quantitative (cross-
sectional with structured 
questionnaires)
•	 Proportion of disclosure
•	 Age of disclosure
•	 Caregiver support
13 Myer et al. 
(34)
Health-care providers’ perspectives 
on discussing HIV status with 
infected children
South Africa 40
•	 Health-care providers at 
a large pediatric clinic
Qualitative (semi-structured 
interviews)
•	 Transition from partial 
disclosure
•	 To full disclosure in children
•	 Best person to disclose
14 Corneli 
et al. (35)
The role of disclosure in relation to 
assent to participate in HIV-related 
research among HIV-infected youth: 
a formative study
Democratic 
Republic of 
Congo
72
•	 19 adolescents living 
with HIV
•	 36 parents and 
caregivers
•	 17 HCPs
Qualitative (semi-structured 
interviews)
•	 Age of disclosure to children
15 Gachanja 
and 
Burkholder 
(36)
Model for HIV disclosure of a 
parent’s and/or a child’s illness
Kenya 34
•	 12 children (7 HIV+ and 
5 HIV− between 8 and 
17 years)
•	 16 HIV+ parents/
caregivers
•	 6 HCPs
Qualitative •	 Facilitators/motivation to 
disclose
•	 Age of disclosure
•	 Associated emotions
•	 Benefits
•	 Negative outcomes
16 Odiachi and 
Abegunde 
(37)
Prevalence and predictors of 
pediatric disclosure among 
HIV-infected Nigerian children on 
treatment
Nigeria •	 110
•	 Parents/caregivers of 
HIV-infected children
Quantitative (semi-structured 
interview)
•	 Prevalence
•	 Age of disclosure
•	 Facilitators
•	 Barriers
17 Toska et al. 
(38)
Sex and secrecy: how HIV-status 
disclosure affects safe sex among 
HIV-positive adolescents
South Africa 858
•	 Adolescents and their 
caregivers
Mixed methods [qualitative 
(interviews, focus group 
discussions and observations 
with 43 HIV-positive 
teenagers and their HCPs; 
quantitative interviewed using 
standardized questionnaires)]
•	 Prevalence of disclosure
•	 Benefits
•	 Barriers
18 Vaz et al. 
(39)
Patterns of disclosure of HIV status 
to infected children in a sub-
Saharan African setting
DR Congo 201
•	 Primary caregivers of 
children 5–17 years old 
in an HIV pediatric care 
and treatment program
Qualitative (structured 
interviews)
•	 Proportion of disclosure
•	 Facilitators
•	 Benefits
•	 Caregiver support in 
disclosure
19 Watermeyer 
(40)
‘Are we allowed to disclose?’: a 
health-care team’s experiences 
of talking with children and 
adolescents about their HIV status
South Africa •	 23 HCPs Qualitative (focus groups) •	 Barriers to disclosure
•	 HCPs disclosure practices
TABLe 1 | Continued
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of disclosure to children (36). Here, the parents of infected 
children were counseled to anticipate and resolve questions 
the children may have prior, during, and following disclosure 
(36). Some other studies reported caregivers who preferred to 
receive counsel from HCPs or HIV counselors before disclosing 
(29, 31, 39). From the time of diagnosis, some participants 
adopted partial disclosure till the children were perceived as 
ready to receive full disclosure (21, 34, 36). Only one of the 
studies clearly described the post-disclosure phase (36). In the 
post-disclosure phase, some of the children in the study had 
TABLe 2 | High level summary of selected articles.
Mburu et al. (23)
Barriers and outcomes of Hiv disclosure
•	 Barriers – local norms that deter parents from communicating 
with their children about sexuality; fear of HIV stigma; and 
an underlying presumption that adolescents would not 
understand the consequences of a HIV diagnosis on their 
lives and relationships
•	 Outcomes: individual level – anxiety, depression, and 
self-blame after disclosure. Interpersonal level – disclosure 
created opportunities for adolescents to access adherence 
support and other forms of psychosocial support from 
family members and peers. At the same time, it occasionally 
strained adolescents’ sexual relationships, although it did not 
always lead to rejection
Watermeyer (40)
Barriers to disclosure and HCPs disclosure practices
•	 Barriers – complexity of the disclosure process, confusion, hesitancy, 
and ethical dilemmas regarding disclosure practices
•	 Disclosure practices among HCPs – tensions were noted within the 
team which seem linked to professional hierarchies. Counselors and 
nurses preferred an indirect approach of encouraging caregivers to 
disclose to their children and providing psychosocial support, while 
doctors tended to become more directly involved in disclosing to 
children out of a sense of duty, legal responsibilities, and knowledge 
of the child’s rights
Demmer (24)
Barriers to disclosure
•	 Stigma to HIV/AIDS in South African society made disclosing 
the child’s HIV status very difficult. There was concern about the 
reaction of partners and family members. Women were afraid of 
being blamed and abandoned. Stigma resulted in delayed testing 
of child and delayed treatment. Conspiracy of silence surrounding 
the child’s HIV status prevailed in many households. Teachers and 
principals were usually not informed about the child’s HIV status 
for fear of discrimination
•	 Perceived immature cognitive development of child, non-
disclosure to most of the children who were under 10 years of age
•	 Caregiver anxiety over future disclosure to their child
De Baets et al. (21)
Age of disclosure and Best person to disclose to child
•	 Age of disclosure – partial disclosure from the age of 
10.8 (±4.2) years and full disclosure from the age of 14.4 
(±4.5) years. HCPs openness to disclosure – compared to 
community members, health-care workers were significantly 
more open to full disclosure and disclosure at a younger age, 
but were slightly less open to discussing grief
•	 Best/preferred person to disclose – HCP in 56% of the 
responses or family member in up to 52%. The most 
commonly preferred family members – father’s sister (up to 
37%) and grandmother (up to 40%) rather than the partner 
(up to 15%). Southern African family dynamics may hinder a 
mother initiating HIV disclosure and discussions about grief, 
even though she is traditionally present during HIV diagnosis, 
counseling, and health education. A more culturally adapted 
approach than the standard western “couple approach” may 
thus be required
Gyamfi et al. (25)
Best person to disclose, proportion, benefits of disclosing and 
elements needed in caregiver support
•	 Most appropriate person to disclose to infected child – caregiver 
(47.5%) with the help of the HCP, caregiver alone (34.7%), and HCP 
(17.8%)
•	 Proportion of disclosure – to infected children and adolescents 
(48.8%), to mother of child (25.6%), and other family members 
(25.6%)
•	 Benefits of disclosure: yes (89%), no (11%). Most (46.6%) – improved 
adherence to medication and 31.4% – reported it promoted 
healthy and responsible sexual behavior when the child became 
an adolescent; 16.9% – made the children and adolescents more 
responsive to their health needs; and 5.1% – helped improve the 
mental and psychological health of the caregiver and/or the child
•	 Support elements: the main supports required by caregivers 
during disclosure included biomedical information, emotional and 
psychological support, and practical guidelines regarding disclosure
Kajubi et al. (26)
Disclosure communication pattern and age (full/partial 
disclosure)
•	 79.6% of the caregivers reported that they explained to the 
children about the medicines, but only half (50.8%) of the children 
were aware the medicines were for HIV.
•	 Older children aged 15–17 years were less likely to communicate 
with a caregiver about the HIV medicines in the preceding month 
(OR 0.5, 95% CI 0.3–0.7, p = 0.002). Children aged 11–14 years 
(OR 6.1, 95% CI 2.8–13.7, p < 0.001) and 15–17 years (OR 12.6, 
95% CI 4.6–34.3, p < 0.001) were more likely to know they were 
taking medicines for HIV compared to the younger ones
•	 The least common reported topic of discussion between children 
and caregivers was “what the medicines are for” while “the time to 
take medicines” was by far the most mentioned by children
Kidia et al. (27)
Best person to disclose, disclosure setting and support
•	 Health-care workers encouraged caregivers to initiate 
disclosure in the home environment
•	 In contrast, many adolescents preferred disclosure to take 
place in the presence of health-care workers at the clinic 
because it gave them access to accurate information as well 
as an environment that made test results seem more credible
•	 Adolescents learned more specific information about living 
with an HIV-positive status and the meaning of that status 
from shared experiences among peers at the clinic
Midtbo et al. (28)
Stigma and coping following disclosure
•	 HIV-status disclosure enabled adolescents to engage effectively with 
their ART treatment and support groups, which in turn provided them 
with a sense of confidence and control over their lives
•	 Although the adolescents in both studies were still experiencing 
stigma from peers and community members, most did not internalize 
these experiences in a negative way, but retained hope for the future 
and felt pity for those untested and uninformed of their own HIV 
status
Corneli et al. (35)
Age of disclosure to children
•	 Parents and caregivers favor disclosure to older children and 
adolescents than younger for HIV-related research
•	 HCPs and caregivers support disclosure to minors because it 
would improve adherence to treatment
(Continued)
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(Continued)
Kiwanuka et al. (30)
Disclosure as a single event or process, benefits and 
barriers
•	 Majority perceived disclosure as a single event rather than a 
process of gradual delivery of information about the child’s 
illness
•	 Benefits – potentially beneficial both to children and 
themselves, an opportunity to explain the parents’ role in the 
transmission of HIV to the children
•	 Barriers – caregivers desired to personally conduct the 
disclosure but most reported being over-whelmed with fear 
of negative outcomes (lack of self-efficacy in managing the 
disclosure process). Most cope by deception to avoid or 
delay disclosure until they perceive their own readiness to 
disclose
Lorenz et al. (31)
Facilitators to testing child, age at disclosure, barriers, type of 
disclosure and support
•	 Facilitators – majority (96%) of respondents, the decision to test the 
child for HIV was due to existing illness in either the child or a relative
•	 Age at disclosure – most (65%) children were informed of their HIV 
status between the ages of 5 and 9, with the mean age of disclosure 
occurring at the age of 7
•	 Barriers – existing stigma within community, doubts about cognitive 
understanding of child
•	 Full disclosure – general provision of HIV information typically began at 
the same age as disclosure
•	 Support in disclosing – two-thirds (64%) of the caregivers sought 
advice from an HIV counselor prior to disclosure
Beima-Sofie et al. (32)
HCPs disclosure practices, family-centered disclosure, best 
Person to disclose and outcomes
•	 HCPs disclosure practices – providers had limited training but 
extensive experience in disclosure, endorsed individualized 
disclosure practices, invested substantial time on disclosure 
despite clinical burden
•	 Family-centered disclosure – child-centered disclosure but should 
respect caregiver fears and values
•	 Best person to disclose – caregiver support was provided to 
enable caregivers to be the person who ultimately disclosed HIV 
status to children
•	 Outcomes – unplanned or abrupt disclosure to children was 
reported to have severe and persistent adverse impact and was 
a stimulus to accelerate disclosure in scenarios when providers 
believed children may be suspecting their diagnosis
Moodley et al. (29)
Disclosure proportion, age of child at disclosure, best 
person, facilitators, and barriers
•	 Only 9% had discussed HIV with the infected child
•	 Mean age of children who had been told their HIV status 
– 8.1 years
•	 Among the 73% of HIV-infected caregivers who had 
discussed their own infection with the child were more than 7 
times more likely to have disclosed the child’s status to him/
her (p = 0.07 after adjusting for age of the child).
•	 Age of disclosure – 12 years was the best age to tell a child 
about his/her HIV infection
•	 Best person to disclose to child – parent or primary caregiver 
(83%), 16% felt it would be best for a health-care provider 
(doctor, nurse or counselor). 25% reported they had 
discussed disclosure of the child’s HIV status with a health-
care provider. Having discussed disclosure with a health-
care provider was associated with disclosure to the child 
(p = 0.07). 96% of those who had not discussed disclosure 
with a health-care provider stated they would like to do
•	 Facilitators to disclosure – 98% of caregivers said they felt 
that the child has a right to know his/her HIV status, 90% 
gave reasons related to the child’s mental health. 70% of 
caregivers said that the availability of ART could make it 
necessary to discuss the child’s HIV status with him/her
•	 Barriers to disclosure – most caregivers (73%) said that they 
were afraid of the child discussing his/her HIV infection with 
other people
Gachanja and Burkholder (36)
Facilitators, age of disclosure, associated emotions, benefits, and 
negative outcomes
•	 Motivation – chronic illness or acute illness presenting with AIDS-
associated symptoms, desire to know HIV status, routine antenatal 
clinic attendance, or during general clinic visits where HCPs 
counseled HIV-positive parents that their children would eventually 
need to receive full disclosure of their own and/or their parents’ HIV 
statuses
•	 Age of disclosure – partial disclosure between 5–9 years of age; non-
disclosure at <5 years
•	 Disclosure process and associated emotions – suspicion by non-
diagnosed children of affected family members, guilt, and depression 
after disclosure
•	 Benefits – for caregivers, there was improved psychological health, 
increased support from their children, increased ability to take 
medications and attend clinic visits openly, improved medication 
adherence, and increased bonding with their children. For HIV-positive 
children, the benefits included increased independence; improved 
self-care, self-medication, and medication adherence; and a greater 
understanding about their HIV statuses, medications, and clinic 
attendance
•	 Negative outcomes – increased stress from rejection by family 
members, disrupted relationships. For HIV-positive children, there was 
drop in school performance; for HIV-negative children there was loss 
of normalcy in daily living, added responsibility at home
Odiachi and Abegunde (37)
Prevalence, age of disclosure, facilitators. and barriers
•	 Prevalence – based on parents/caregivers’ accounts, 34 (30.9%) 
children knew that they were living with HIV, while 74 (67.3%) did 
not know
•	 Age at disclosure – mean age at disclosure was 10.47 years 
(± 2.62), with a median (range) of 10.00 (6–17) years
•	 Disclosure setting – 79.4% were disclosed at home by their 
parents/caregivers, rest at the hospital (5 by HCP; 2 accidental 
disclosure)
•	 Facilitators to disclosure – the most common reasons for 
disclosure were related to adherence issues – either to help 
prepare the children to take their medicines or that the child had 
refused to take his/her medicines (39.4%). This was followed 
by the child asking a lot of questions related to his/her health, 
frequent visits to the hospital, or why s/he was taking a lot of 
medicines even though s/he did not feel ill (27.3%)
•	 Barriers – most parents/caregivers did not disclose because 
the child was considered too young (84.0%) or will not be able 
to keep their HIV status a secret (10.7%). Multivariate logistic 
regression showed that only child’s age was a statistically 
significant predictor of status disclosure (OR 1.69, p = 0.002; 
95% CI 1.21–2.34). There was no association between disclosure 
and self-reported adherence (p = 0.615).
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questions about transmission of the disease, HIV management, 
and eventual cure (36).
Persons Best to Disclose
Persons best positioned to disclose varied in different studies 
and by the key participants asked. Majority of the studies that 
explored “persons best to disclose” favored disclosure by caregiv-
ers with support from HCPs (27, 29, 31–34). One study reported 
preference for HCPs disclosing rather than caregivers (25). Two 
studies among caregivers in South Africa and Uganda reported 
high preference for the parent or caregiver to disclose rather than 
HCPs (29, 30). A study in Uganda and Kenya indicated that HCPs 
support caregivers when they initiate disclosure (27, 32), but ado-
lescents preferred HCPs to disclose rather than their caregivers 
because they had an opportunity for more accurate information 
about their disease (27). A study in South Africa indicated that 
caregivers preferred that the HCP or family members, especially 
the paternal aunt and grandmother disclose rather than the 
mother (21). Although some caregivers preferred to disclose to 
infected children themselves, they expressed fears of competence 
in disclosure; acceptance by the child; stigma from accidental 
disclosure by the child to others; and need for support (29, 31, 
32, 34, 39).
Approach to Disclosure
Perspectives of different groups of HCPs differed on approach to 
disclosure. Nurses and counselors shared preference for encour-
aging caregivers to disclose to their children and adolescents 
with adequate support (40), unlike doctors who preferred direct 
participation in disclosure from a professional and legal obliga-
tion (32, 40). HCPs experienced conflict between human rights or 
public health safety during disclosure and also required training 
in decision-making and to reduce inadvertent disclosure (37). 
When HCPs were to discuss grief or HIV diagnosis with children 
and adolescents, HCPs preferred full disclosure of HIV diagnosis 
to children at a younger age (6–15 years) rather than discussing 
grief. In contrast, caregivers preferred that children were older 
(10–19  years) since they were more open to discussing grief 
than HIV.
Disclosure Setting
Disclosure setting was an important consideration in the disclo-
sure process according to some of the studies. The health facility 
setting was preferred by HCPs because this provided an avenue 
for caregiver support during the disclosure process (32), and also 
gave adolescents the opportunity to obtain reliable answers to 
questions and interact with peers at the health facility (27, 28). 
For caregivers who preferred their HCPs to be involved in the 
disclosure process, the health facility was the natural setting 
where this occurred (29, 33, 34, 40). Where caregivers preferred 
to handle disclosure to their minors, the home setting was the 
natural environment (30).
Barriers and Outcomes of Hiv Disclosure
Barriers to disclosure by HCPs or caregivers included the fear of 
HIV stigma, uncertainty about cognitive development of chil-
dren, and local traditions that limit discussion of sexuality (23, 
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24, 29, 36). Some studies described benefits from the disclosure 
process, and this included improved ART adherence and mental 
health of affected individuals (25, 35), opportunity to cope with 
the illness, and the associated stigma (27, 28, 30). By contrast, 
a study reported adolescents who experienced peer-stigma, 
anxiety, depression, and self-blame after knowing their positive 
status (28). Furthermore, some studies indicated that disclosure, 
especially premature or inadvertent disclosure, resulted in harm-
ful outcomes such as stigma, discrimination, and abuse from 
family and community members (23, 28, 32, 36). Some caregivers 
coped by adopting a conspiracy of silence (24). Besides, a study 
in Democratic Republic of Congo reported up to one-third of 
caregivers who did not see any benefit in disclosing to children 
(39). In addition, a study involving HCPs and adolescents indi-
cated that adolescents did not see any benefit in knowing their 
partner’s status nor disclosing to a partner (38). Rather, benefit 
was reported from knowing self-status as this informed safer 
sexual lifestyle (38). While one study suggested that disclosure 
may empower the child or adolescent to engage in safe sexual 
behaviors (25), another study indicated there was no correla-
tion with sexual lifestyle but with medication adherence (38). 
Caregivers or other family members also had to disclose their 
HIV status to facilitate the communication of perinatal infection 
and ART adherence to infected children and adolescents (24, 
29, 36). However, some caregivers expressed concerns that this 
process could generate both positive and negative outcomes 
(24, 29, 36).
DiSCUSSiON
The objective of this review was to explore the perspectives and 
practices of HCPs and caregivers in HIV disclosure to children 
and adolescents. Findings are categorized as follows: types and 
prevalence of disclosure; facilitators, timing and barriers; process 
of disclosure; persons best to disclose, approach to disclosure by 
HCP versus caregivers; suitable disclosure setting and outcomes 
of disclosure.
This review showed that the prevalence of full disclosure is 
relatively low for children compared to adolescents, which is 
higher (37, 38). However, the prevalence of HIV disclosure needs 
to be improved for both age groups because more disclosure will 
reduce the number of infected children and adolescents at risk of 
morbidity and mortality from poor adherence to ARTs (23, 28, 
32, 36). Despite natural concerns of adults about a child’s ability 
to cope with disclosure, empirical studies show that children may 
be more resilient than assumed (42, 43), appropriate disclosure 
may enhance psychological stability of the child and improve 
adherence to ART therapy (28, 42, 44). For adolescents, more 
disclosure by HCPs or caregivers to infected adolescents directly 
will encourage safer sexual behaviors that reduce new HIV trans-
mission rather than emphasizing adolescents disclosing to their 
partners (38).
In SSA, variation exists in the types of disclosure in practice, 
and this review has highlighted studies where participants utilized 
partial disclosure before full disclosure of HIV-positive status or 
adopted outright non-disclosure (21, 26, 33, 34, 36, 41). Most 
studies identified the age of a child as a key factor that determined 
the timing of disclosure. It is important to identify cues to disclo-
sure to children early since appropriate training for HCPs and 
caregivers may enhance their readiness to disclose. Age, as a key 
factor, also emerged in a systematic review by Vreeman et al. on 
pediatric disclosure practices in resource-limited settings (20). 
Most of the studies in this review suggest that, in SSA, partial 
disclosure may be appropriate for children up to early adoles-
cence (21, 22, 34, 36), and this is consistent with the report from 
WHO Guideline on HIV Disclosure Counselling for Children up 
to 12 years of Age (2011) (12, 43). Despite age as a key factor in 
disclosure to children, we recommend that consideration needs 
to be given to communication patterns within families, orphan 
status, cultural norms, influence of other family members living 
with HIV/AIDS, and involvement of the child in administering 
ART medications (33, 36, 37).
Again, this review indicated that the concept of HIV disclo-
sure process is relatively understudied since few studies evalu-
ated perception of HCPs and caregivers. Caregivers described 
the disclosure process as complex, and one study reported 
caregivers who viewed disclosure as a solitary event. To reduce 
the complexity associated with disclosure, it is important to dis-
seminate HIV disclosure as a process originating from the time 
of initial diagnosis to events beyond disclosure. Here, a series of 
dialog is made with the child about the terms, course of disease, 
relationship with others, self-care, and medications over time 
(36, 45). The dialog between caregivers and their children may 
be strengthened by providing focused counseling to caregivers 
throughout the disclosure process (42, 43, 46). Scientific research 
has demonstrated that the process-oriented approach results in 
less strain on caregivers and better outcomes for infected children 
and adolescents (28, 36, 42, 44, 47).
From the selected studies, there was evidence that both 
HCPs and caregivers perceived the most suitable individuals to 
disclose to children in SSA are caregivers, with support from 
HCPs throughout the process (27, 31, 32, 35, 37, 41). The WHO 
guideline on disclosure counseling to children under 12 years of 
age (2011) indicated that there is no evidence for either HCPs 
or caregivers disclosure as the best to disclose, but emphasized 
that disclosure should be in the best interest of the child (12). 
Adolescents had a preference for disclosure by the HCP because 
they received more biomedical information and could cope better 
with the disease than information received from their caregivers 
alone (27). Adolescents also indicated that peer-group support 
was important to them (23, 27). This suggests that the support 
needs of adolescents during the disclosure process differ from 
those of younger children in the region.
The health-care setting also plays a critical role in disclosure 
practice. Among HCPs, physicians tended to disclose more 
directly from a legal, moral, and ethical obligations compared 
to other workers who emphasized provision of support to car-
egivers who should disclose directly to infected children (40). 
As more HCPs disclose, it is critical to expand the locations where 
their services can be accessed by affected families. A review by 
Obermeyer and colleagues provided evidence that increased 
HIV/AIDS services in areas with limited services may facilitate 
disclosure and reduce stigma in the affected communities (46). 
Creating more health-care centers for HIV/AIDS services is 
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an additional cost in resource-limited parts of the SSA, but the 
World Health Organization, in 2015, recommended HIV coun-
seling and testing by trained lay providers (community health 
workers) to reduce the cost of providing needed services and to 
increase access to care (48). Some success is being recorded with 
lay providers in this regard, but this strategy requires more stud-
ies and careful review of existing policies to seamlessly integrate 
lay providers in provision of counseling and testing services 
(49–51).
Stigma and discrimination remain a persistent threat to the 
potential benefits of HIV disclosure. Sadly, local norms that 
deter discussion of sexuality also indirectly limit HIV disclosure 
by their HCPs and caregivers to children and adolescents (23). 
While advocating for any type of disclosure, it is important to 
consider individual rights and safety carefully balanced with 
public health safety.
Limitations
Some limitations are inherent in this review. For example, 
although our review focused on SSA, not all countries in this 
region had adequate research available on HIV disclosure by 
HCPs and caregivers. SSA was only represented by 10 countries 
out of 46 (Botswana, Democratic Republic Congo, Ghana, 
Kenya, Nigeria, South Africa, Tanzania, Uganda, Zambia, and 
Zimbabwe). Four studies performed prior to or during the period 
(2008) of increased access to ART in SSA may not have clearly 
depicted the current disclosure process and practices because of 
the recent discovery of a relationship between access to ART and 
HIV disclosure (7, 29, 34). Reported perspectives and practices 
may slightly differ in the health-care setting or living situation of 
participants; therefore, caution must be applied in interpretation 
of the findings and in making generalizations.
The quality of the studies varied especially with majority 
consisting of convenience sampling. Restricting the search to 
English-language publications may have excluded studies or 
participants from non-English speaking parts of SSA. Paucity 
of research on this topic limited the discussion of several other 
issues, such as specific disclosure communication and practices. 
Studies on prevalence and proportions of disclosed patients were 
largely for children and relatively less for adolescent, again limit-
ing the scope of the review.
implication
Because timing is an important factor to consider, best prac-
tices would have to include training of HCPs and caregivers to 
identify appropriate timing for disclosure, especially at the early 
phase of diagnosis (43). Continuing education and training that 
incorporate health policies and are amenable to local norms may 
contribute to the efficacy of HCPs when addressing barriers to 
HIV disclosure in their communities (48). Since the advent of 
more available ART, the focus has been on prompt diagnosis, 
prevention of mother-to-child transmission (PMTCT), partner 
disclosure, and testing with some success in HIV risk behavioral 
changes. However, success in individual behavior change will 
remain a challenge where the route of transmission involves at 
least two individuals or children infected perinatally. Findings 
from this review indicate the importance of broadening the scope 
of current HIV intervention programs to include adequately 
informed and appropriate disclosure. Therefore, long-term HIV/
AIDS program funding should provide for resources to ensure 
that disclosure does not stop at informing individuals (e.g., 
infected mothers) of their HIV status or encouraging ART adher-
ence; rather these resources should also be channeled to ensure 
adequate counseling and support after disclosure to minimize 
stigma, abuse, poor ART adherence, and transmission of new 
HIV infection.
Peer groups are helpful to adolescents but require participa-
tion of motivated members living with HIV and ought to be 
facilitated by trained personnel (27, 28). Although two studies 
among adolescents referred to peer support as a coping method 
for this population, stigma from peers was a reality in other stud-
ies (27, 28, 33). Therefore, when peer groups are being facilitated 
by HCPs, caution must be exercised to ensure appropriate groups 
are created and proactive measures undertaken to minimize 
stigma from peers.
The role of HCPs in HIV disclosure is challenged by insuffi-
cient number of HCPs relative to the sub-Saharan population (52, 
53). Poor training, difficult working conditions, and increasing 
emigration to urban areas and developed countries has contrib-
uted to HCP shortage in about 31 countries in SSA (52, 53). The 
shortage in HCPs who daily endure stressful working conditions 
inadvertently impinge on optimal disclosure practices. To reduce 
the burden on HCPs, trained lay providers (community health 
workers) should be integrated in the disclosure process. Also, the 
responsibility to disclose can be shared equally by all cadres of 
HCPs trained in HIV disclosure, and team work should be driven 
by a patient-centered approach to caring for infected children 
and adolescents. An extension of this collaboration is a family-
centered approach, where the health-care team collaborates with 
family members (or caregivers) directly involved in the care of the 
child at home or with individuals selected by family members to 
represent them (21, 43).
The ethical issues involved in disclosure have contributed to 
the complexity associated with establishing specific HIV disclo-
sure guidelines in SSA (7, 8). To get the best result from disclo-
sure, HCPs need to disclose in the most ethical and culturally 
competent manner with full inclusion of patient confidentiality. 
Broad guidelines may be more effective for SSA as this lends itself 
to accommodate the cultural diversity of each country and even 
regions within specific countries. From these broad guidelines, 
hospital or clinic leaders can provide specific guidelines based on 
the local context as this would be helpful to HCPs and caregiv-
ers when taking care of their patients and children, respectively. 
Beyond the perspectives of HCPs and caregivers, the perspectives 
of people and communities with high HIV burden need to be 
incorporated in revising or creating local guidelines on HIV 
disclosure. Other factors, such as facilitators and barriers associ-
ated with HIV disclosure to children and adolescents, need to be 
factored into new guidelines. The degree to which these broad 
factors are considered in the development and implementation 
process will likely result in a more successful adoption of disclo-
sure guidelines.
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CONCLUSiON
This review evaluated the perspectives of HIV disclosure and 
practices currently used in delivering age- and culture-sensitive 
HIV disclosure to children and adolescents by health caregivers 
or caregivers in SSA. Further evidence has been generated on 
the emerging topic of HIV disclosure in this region following 
the advent of ART. Partial disclosure is appropriate for children 
in SSA up to early adolescence. Caregivers should be involved 
in disclosing to children, and they require adequate disclosure 
support from HCPs. On the other hand, full disclosure is suitable 
for adolescents. Adolescents prefer disclosure by HCPs and they 
favor peer-group support from committed peers and trained 
facilitators, to reduce stigma. HCPs need continuous training 
and adequate resources to disclose in a patient-centered manner. 
Community members need education in HIV stigma reduction.
The evidence-based information from this review informed 
the following recommendations. First, caregivers and HCPs 
require collaborative training to ensure the best interest of infected 
children and adolescents are addressed throughout the disclosure 
process. Second, public health education should promote HIV/
AIDS as a shared burden and create opportunities for community 
members to accept families of children and adolescents living 
with HIV to reduce stigma in the communal life. Inclusion of 
trained lay providers selected from affected communities may also 
ensure more culturally acceptable management of HIV disclosure 
in these communities. Third, family counseling and community 
education that encourages discussion of sexuality within local 
norms will empower children and adolescents to make better 
informed sexual health- or HIV-related choices. Finally, more 
studies are needed to determine the role of social determinants 
in HIV disclosure practices in resource-limited communities.
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